Medicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy
Patients from states that had an early expansion of Medicaid and patients with lower-grade tumors had significantly better overall survival. Our study findings suggest that improved access to healthcare through Medicaid expansion was associated with increased survival rates of lower gastrointestinal cancer patients who undergo CRS+HIPEC for the treatment of peritoneal metastases.
Authors
- Michael P. O’Leary (ORCID: https://orcid.org/0000-0002-4756-4271)
- David Caba Molina (ORCID: https://orcid.org/0000-0002-4359-3315)
- Kirithiga Ramalingam (ORCID: https://orcid.org/0000-0002-1774-6891)
- Sharon S. Lum (ORCID: https://orcid.org/0000-0001-5097-9032)
- Liang Ji
Institutions
- University of California, San Francisco (US)
- University of California, Irvine (US)
- Loma Linda University (US)
- Riverside University Health System - Medical Center (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2024-11-15
- DOI
- https://doi.org/10.1245/s10434-024-16446-8
- Citations
- 3
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 1.72
Funders
- Loma Linda University